A phase I study of sorafenib with FOLFIRI as first-line therapy for metastatic colorectal cancer (mCRC): Safety and efficacy results.
Jean Alfred Maroun
No relevant relationships to disclose
Derek J. Jonker
No relevant relationships to disclose
M. Christine Cripps
No relevant relationships to disclose
Timothy R. Asmis
No relevant relationships to disclose
Rakesh Goel
No relevant relationships to disclose
Rachel Anne Goodwin
No relevant relationships to disclose
Horia Marginean
No relevant relationships to disclose